People have been talking so much about the effectiveness and high value of GLP-1 drugs because of their effects not just on weight but also cardiovascular disease, metabolic health, and more, said first author David Kim, PhD, a health economist at UChicago
If the research question is broad melanocortin receptor pharmacology, Melanotan-2 may be relevant, but it also brings more off-target interpretive baggage
10 : 1123 Sunderland T, Molchan SE, Zubenko GS
[DOI] [PubMed] [Google Scholar] 4.Siponen M, Salo T
Baseline Risk Factors and Biomarker Assessment Before initiating GLP-1 therapy, providers should evaluate individual predispositions to fungal infection
Several potential mechanisms were examined from metabolic to endocrine to immune mediators which could underlie the significant reductions in tumor burden